Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.
Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania.
Clin Gastroenterol Hepatol. 2023 Oct;21(11):2727-2739.e1. doi: 10.1016/j.cgh.2023.05.025. Epub 2023 Jun 9.
BACKGROUND & AIMS: Anorectal manometry (ARM) is a comprehensive diagnostic tool for evaluating patients with constipation, fecal incontinence, or anorectal pain; however, it is not widely utilized for reasons that remain unclear. The aim of this roundtable discussion was to critically examine the current clinical practices of ARM and biofeedback therapy by physicians and surgeons in both academic and community settings.
Leaders in medical and surgical gastroenterology and physical therapy with interest in anorectal disorders were surveyed regarding practice patterns and utilization of these technologies. Subsequently, a roundtable was held to discuss survey results, explore current diagnostic and therapeutic challenges with these technologies, review the literature, and generate consensus-based recommendations.
ARM identifies key pathophysiological abnormalities such as dyssynergic defecation, anal sphincter weakness, or rectal sensory dysfunction, and is a critical component of biofeedback therapy, an evidence-based treatment for patients with dyssynergic defecation and fecal incontinence. Additionally, ARM has the potential to enhance health-related quality of life and reduce healthcare costs. However, it has significant barriers that include a lack of education and training of healthcare providers regarding the utility and availability of ARM and biofeedback procedures, as well as challenges with condition-specific testing protocols and interpretation. Additional barriers include understanding when to perform, where to refer, and how to use these technologies, and confusion over billing practices.
Overcoming these challenges with appropriate education, training, collaborative research, and evidence-based guidelines for ARM testing and biofeedback therapy could significantly enhance patient care of anorectal disorders.
肛门直肠测压(ARM)是一种全面的诊断工具,可用于评估便秘、粪便失禁或肛门直肠疼痛的患者;然而,由于某些原因,它并未得到广泛应用,具体原因尚不清楚。本次圆桌讨论的目的是批判性地检查 ARM 和生物反馈疗法在学术和社区环境中医生和外科医生的当前临床实践。
对有兴趣了解肛门直肠疾病的医学和外科胃肠病学以及物理治疗领域的领导者进行了关于实践模式和这些技术的使用情况的调查。随后,举行了一次圆桌会议,讨论调查结果,探讨这些技术的当前诊断和治疗挑战,回顾文献,并生成基于共识的建议。
ARM 可识别出关键的生理病理异常,如协同性排便障碍、肛门括约肌无力或直肠感觉功能障碍,是生物反馈治疗的重要组成部分,生物反馈治疗是协同性排便障碍和粪便失禁患者的一种循证治疗方法。此外,ARM 还有潜力提高与健康相关的生活质量并降低医疗保健成本。然而,它存在一些重大障碍,包括医疗保健提供者对 ARM 和生物反馈程序的实用性和可用性缺乏教育和培训,以及与特定疾病的测试协议和解释相关的挑战。其他障碍包括了解何时进行、向何处转介以及如何使用这些技术,以及计费实践方面的困惑。
通过适当的教育、培训、合作研究以及针对 ARM 测试和生物反馈疗法的循证指南来克服这些挑战,可以显著提高肛门直肠疾病患者的护理水平。